{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,27]],"date-time":"2026-07-27T18:17:40Z","timestamp":1785176260022,"version":"3.55.0"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2010,11,26]],"date-time":"2010-11-26T00:00:00Z","timestamp":1290729600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["World J Urol"],"published-print":{"date-parts":[[2011,2]]},"DOI":"10.1007\/s00345-010-0618-3","type":"journal-article","created":{"date-parts":[[2010,11,25]],"date-time":"2010-11-25T06:24:36Z","timestamp":1290666276000},"page":"51-57","source":"Crossref","is-referenced-by-count":35,"title":["Five-year cost analysis of intra-detrusor injection of botulinum toxin type A and augmentation cystoplasty for refractory neurogenic detrusor overactivity"],"prefix":"10.1007","volume":"29","author":[{"given":"Priya","family":"Padmanabhan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harriette M.","family":"Scarpero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Douglas F.","family":"Milam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roger R.","family":"Dmochowski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David F.","family":"Penson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2010,11,26]]},"reference":[{"key":"618_CR1","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1016\/S0090-4295(98)00220-9","volume":"52","author":"S Herschorn","year":"1998","unstructured":"Herschorn S, Hewitt RJ (1998) Patient perspective of long-term outcome of augmentation cystoplasty for neurogenic bladder. Urology 52:672","journal-title":"Urology"},{"key":"618_CR2","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1002\/(SICI)1520-6777(1999)18:2<139::AID-NAU9>3.0.CO;2-U","volume":"18","author":"M Stohrer","year":"1999","unstructured":"Stohrer M, Schurch B, Kramer G et al (1999) Botulinum A-toxin in the treatment of detrusor hyperreflexia in spinal cord injured patients: a new alternative to medical and surgical procedures? Neurourol Urodyn 18:401","journal-title":"Neurourol Urodyn"},{"key":"618_CR3","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1016\/j.eururo.2003.12.004","volume":"45","author":"A Reitz","year":"2004","unstructured":"Reitz A, Stohrer M, Kramer G et al (2004) European experience of 200 cases treated with botulinum-A toxin injections into the detrusor muscle for urinary incontinence due to neurogenic detrusor overactivity. Eur Urol 45:510","journal-title":"Eur Urol"},{"key":"618_CR4","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1016\/j.urology.2006.08.1069","volume":"68","author":"G Karsenty","year":"2006","unstructured":"Karsenty G, Reitz A, Lindemann G et al (2006) Persistence of therapeutic effect after repeated injections of botulinum toxin type A to treat incontinence due to neurogenic detrusor overactivity. Urology 68:1193","journal-title":"Urology"},{"key":"618_CR5","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1016\/j.eururo.2008.02.037","volume":"53","author":"A Apostolidis","year":"2008","unstructured":"Apostolidis A, Jacques TS, Freeman A et al (2008) Histological changes in the urothelium and suburothelium of human overactive bladder following intradetrusor injections of botulinum neurotoxin type A for the treatment of neurogenic or idiopathic detrusor overactivity. Eur Urol 53:1245","journal-title":"Eur Urol"},{"key":"618_CR6","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1016\/j.eururo.2005.11.006","volume":"49","author":"V Kalsi","year":"2006","unstructured":"Kalsi V, Popat RB, Apostolidis A et al (2006) Cost-consequence analysis evaluating the use of botulinum neurotoxin-A in patients with detrusor overactivity based on clinical outcomes observed at a single UK centre. Eur Urol 49:519","journal-title":"Eur Urol"},{"key":"618_CR7","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/S1569-9056(08)60562-X","volume":"7","author":"S Boy","year":"2008","unstructured":"Boy S, Seif C, Braun P (2008) Retrospective analysis of treatment outcomes and medical care of patients with neurogenic detrusor overactivity (NDO) receiving BOTOX therapy. Eur Urol Suppl 7:212","journal-title":"Eur Urol Suppl"},{"key":"618_CR8","doi-asserted-by":"crossref","first-page":"A663","DOI":"10.1016\/S1569-9056(04)90658-6","volume":"3","author":"G Del Popolo","year":"2004","unstructured":"Del Popolo G, Li Marzi V, Lombardi G (2004) Efficacy, safety and dosage of English botulinum toxin-A in neurogenic detrusor overactivity. Eur Urol 3:A663","journal-title":"Eur Urol"},{"key":"618_CR9","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1016\/j.eururo.2007.09.034","volume":"53","author":"G Del Popolo","year":"2008","unstructured":"Del Popolo G, Filocamo MT, Li Marzi V et al (2008) Neurogenic detrusor overactivity treated with English botulinum toxin a: 8-year experience of one single centre. Eur Urol 53:1013","journal-title":"Eur Urol"},{"key":"618_CR10","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1016\/j.eururo.2004.11.009","volume":"47","author":"J Grosse","year":"2005","unstructured":"Grosse J, Kramer G, Stohrer M (2005) Success of repeat detrusor injections of botulinum a toxin in patients with severe neurogenic detrusor overactivity and incontinence. Eur Urol 47:653","journal-title":"Eur Urol"},{"key":"618_CR11","doi-asserted-by":"crossref","first-page":"1729","DOI":"10.1016\/j.eururo.2007.08.052","volume":"52","author":"A Reitz","year":"2007","unstructured":"Reitz A, Denys P, Fermanian C et al (2007) Do repeat intradetrusor botulinum toxin type a injections yield valuable results? Clinical and urodynamic results after five injections in patients with neurogenic detrusor overactivity. Eur Urol 52:1729","journal-title":"Eur Urol"},{"key":"618_CR12","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1016\/j.annrmp.2007.03.019","volume":"50","author":"A Chenet","year":"2007","unstructured":"Chenet A, Perrouin-Verbe B, Le Normand L et al (2007) Efficacy of repeat injections of botulinum A toxin to the detrusor in neurogenic bladder overactivity. Ann Readapt Med Phys 50:651","journal-title":"Ann Readapt Med Phys"},{"key":"618_CR13","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1016\/j.eururo.2008.08.048","volume":"55","author":"A Giannantoni","year":"2009","unstructured":"Giannantoni A, Mearini E, Del Zingaro M et al (2009) Six-year follow-up of botulinum toxin A intradetrusorial injections in patients with refractory neurogenic detrusor overactivity: clinical and urodynamic results. Eur Urol 55:705","journal-title":"Eur Urol"},{"key":"618_CR14","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/j.eururo.2007.10.013","volume":"53","author":"G Karsenty","year":"2008","unstructured":"Karsenty G, Denys P, Amarenco G et al (2008) Botulinum toxin A (Botox) intradetrusor injections in adults with neurogenic detrusor overactivity\/neurogenic overactive bladder: a systematic literature review. Eur Urol 53:275","journal-title":"Eur Urol"},{"key":"618_CR15","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1097\/01.ju.0000162035.73977.1c","volume":"174","author":"B Schurch","year":"2005","unstructured":"Schurch B, de Seze M, Denys P et al (2005) Botulinum toxin type a is a safe and effective treatment for neurogenic urinary incontinence: results of a single treatment, randomized, placebo controlled 6-month study. J Urol 174:196","journal-title":"J Urol"},{"key":"618_CR16","first-page":"79","volume":"56","author":"A Giannantoni","year":"2004","unstructured":"Giannantoni A, Mearini E, Di Stasi SM et al (2004) New therapeutic options for refractory neurogenic detrusor overactivity. Minerva Urol Nefrol 56:79","journal-title":"Minerva Urol Nefrol"},{"key":"618_CR17","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1080\/00365590410015867","volume":"38","author":"P Bagi","year":"2004","unstructured":"Bagi P, Biering-Sorensen F (2004) Botulinum toxin A for treatment of neurogenic detrusor overactivity and incontinence in patients with spinal cord lesions. Scand J Urol Nephrol 38:495","journal-title":"Scand J Urol Nephrol"},{"key":"618_CR18","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1016\/S0022-5347(05)67283-7","volume":"164","author":"B Schurch","year":"2000","unstructured":"Schurch B, Stohrer M, Kramer G et al (2000) Botulinum-A toxin for treating detrusor hyperreflexia in spinal cord injured patients: a new alternative to anticholinergic drugs? Preliminary results. J Urol 164:692","journal-title":"J Urol"},{"key":"618_CR19","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1002\/nau.20153","volume":"25","author":"H Schulte-Baukloh","year":"2006","unstructured":"Schulte-Baukloh H, Schobert J, Stolze T et al (2006) Efficacy of botulinum-A toxin bladder injections for the treatment of neurogenic detrusor overactivity in multiple sclerosis patients: an objective and subjective analysis. Neurourol Urodyn 25:110","journal-title":"Neurourol Urodyn"},{"key":"618_CR20","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1016\/j.eururo.2005.12.012","volume":"49","author":"V Kalsi","year":"2006","unstructured":"Kalsi V, Apostolidis A, Popat R et al (2006) Quality of life changes in patients with neurogenic versus idiopathic detrusor overactivity after intradetrusor injections of botulinum neurotoxin type A and correlations with lower urinary tract symptoms and urodynamic changes. Eur Urol 49:528","journal-title":"Eur Urol"},{"key":"618_CR21","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1016\/j.urology.2003.12.007","volume":"63","author":"HC Kuo","year":"2004","unstructured":"Kuo HC (2004) Urodynamic evidence of effectiveness of botulinum A toxin injection in treatment of detrusor overactivity refractory to anticholinergic agents. Urology 63:868","journal-title":"Urology"},{"key":"618_CR22","doi-asserted-by":"crossref","first-page":"2114","DOI":"10.1016\/j.apmr.2005.06.008","volume":"86","author":"J Klaphajone","year":"2005","unstructured":"Klaphajone J, Kitisomprayoonkul W, Sriplakit S (2005) Botulinum toxin type A injections for treating neurogenic detrusor overactivity combined with low-compliance bladder in patients with spinal cord lesions. Arch Phys Med Rehabil 86:2114","journal-title":"Arch Phys Med Rehabil"},{"key":"618_CR23","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1310\/1640-XEPP-Y33E-TMK8","volume":"8","author":"M Kennelly","year":"2003","unstructured":"Kennelly M, Kang J (2003) Botulinum-A toxin injections as a treatment for refractory detrusor hyperreflexia. Top Spinal Cord in J Rehabil 8:46","journal-title":"Top Spinal Cord in J REhabil"},{"key":"618_CR24","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.1111\/j.1464-410X.2009.08600.x","volume":"104","author":"J Pannek","year":"2009","unstructured":"Pannek J, Gocking K, Bersch U (2009) Long-term effects of repeated intradetrusor botulinum neurotoxin A injections on detrusor function in patients with neurogenic bladder dysfunction. BJU Int 104:1246","journal-title":"BJU Int"},{"key":"618_CR25","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1111\/j.1464-410X.1994.tb07545.x","volume":"73","author":"ER Freedman","year":"1994","unstructured":"Freedman ER, Singh G, Donnell SC et al (1994) Combined bladder neck suspension and augmentation cystoplasty for neuropathic incontinence in female patients. Br J Urol 73:621","journal-title":"Br J Urol"},{"key":"618_CR26","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/S0022-5347(17)36657-0","volume":"148","author":"B Blyth","year":"1992","unstructured":"Blyth B, Ewalt DH, Duckett JW et al (1992) Lithogenic properties of enterocystoplasty. J Urol 148:575","journal-title":"J Urol"},{"key":"618_CR27","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/S0094-0143(99)80010-X","volume":"26","author":"RC Rink","year":"1999","unstructured":"Rink RC (1999) Bladder augmentation. Options, outcomes, future. Urol Clin North Am 26:111","journal-title":"Urol Clin North Am"},{"key":"618_CR28","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1046\/j.1464-4096.2001.001206","volume":"88","author":"TJ Greenwell","year":"2001","unstructured":"Greenwell TJ, Venn SN, Mundy AR (2001) Augmentation cystoplasty. BJU Int 88:511","journal-title":"BJU Int"},{"key":"618_CR29","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1038\/sj.sc.3101033","volume":"38","author":"EJ Chartier-Kastler","year":"2000","unstructured":"Chartier-Kastler EJ, Mongiat-Artus P, Bitker MO et al (2000) Long-term results of augmentation cystoplasty in spinal cord injury patients. Spinal Cord 38:490","journal-title":"Spinal Cord"},{"key":"618_CR30","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1046\/j.1464-4096.2001.gough.2464.x","volume":"88","author":"DC Gough","year":"2001","unstructured":"Gough DC (2001) Enterocystoplasty. BJU Int 88:739","journal-title":"BJU Int"},{"key":"618_CR31","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1159\/000067708","volume":"70","author":"R Zachoval","year":"2003","unstructured":"Zachoval R, Pitha J, Medova E et al (2003) Augmentation cystoplasty in patients with multiple sclerosis. Urol Int 70:21","journal-title":"Urol Int"},{"key":"618_CR32","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1016\/j.eururo.2007.08.039","volume":"53","author":"X Game","year":"2008","unstructured":"Game X, Castel-Lacanal E, Bentaleb Y et al (2008) Botulinum toxin A detrusor injections in patients with neurogenic detrusor overactivity significantly decrease the incidence of symptomatic urinary tract infections. Eur Urol 53:613","journal-title":"Eur Urol"},{"key":"618_CR33","doi-asserted-by":"crossref","unstructured":"Chancellor MB (2009) Ten years single surgeon experience with botulinum toxin in the urinary tract; clinical observations and research discovery. Int Urol Nephrol","DOI":"10.1007\/s11255-009-9600-7"}],"container-title":["World Journal of Urology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00345-010-0618-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00345-010-0618-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00345-010-0618-3","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,6]],"date-time":"2019-06-06T10:51:31Z","timestamp":1559818291000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00345-010-0618-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,11,26]]},"references-count":33,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2011,2]]}},"alternative-id":["618"],"URL":"https:\/\/doi.org\/10.1007\/s00345-010-0618-3","relation":{},"ISSN":["0724-4983","1433-8726"],"issn-type":[{"value":"0724-4983","type":"print"},{"value":"1433-8726","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,11,26]]}}}